Investor Relations

Bursa Announcements

Year :

2026 2025 2024 2023 2022 Archives

Select Date Range :

Categories :

Filter Reset
Tuesday - 2 Sep 2025
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Friday - 29 Aug 2025
Change in Boardroom - DATUK MOHD ADZAHAR ABDUL WAHID
Tuesday - 26 Aug 2025
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2025
Wednesday - 6 Aug 2025
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
Friday - 1 Aug 2025
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Thursday - 31 Jul 2025
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - JAKEL MEDICAL SDN BHD
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - LEMBAGA TABUNG ANGKATAN TENTERA
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BOUSTEAD HOLDINGS BERHAD
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
Tuesday - 29 Jul 2025
Additional Listing Announcement /Subdivision of Shares
Additional Listing Announcement /Subdivision of Shares
Thursday - 24 Jul 2025
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
Wednesday - 2 Jul 2025
RENOUNCEABLE RIGHTS ISSUE OF UP TO 3,521,543,102 NEW ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") ("PHARMANIAGA SHARES" OR "SHARES") ("RIGHTS SHARES") AT AN ISSUE PRICE OF RM0.10 PER RIGHTS SHARE ON THE BASIS OF 12 RIGHTS SHARES FOR EVERY 5 EXISTING PHARMANIAGA SHARES HELD AS AT 5.00 P.M. ON WEDNESDAY, 2 JULY 2025 ("RIGHTS ISSUE")
Tuesday - 1 Jul 2025
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT